Presage, Millennium in cancer deal

Presage Biosciences (Seattle, Wash.) partnered with the Millennium Pharmaceuticals Inc. subsidiary of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) to use Presage's technology for preclinical identification of effective drug combinations in solid tumors. Presage will receive upfront fees and research funding, and is eligible for milestones related to identification of successful drug combinations. ...